Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply

Aliment Pharmacol Ther. 2020 Aug;52(3):557-558. doi: 10.1111/apt.15875.

Perttu Lahtinen^{1

2}, Jonna Jalanka³, Anna Hartikainen³, Eero Mattila⁴, Markku Hillilä^{2

5}, Jari Punkkinen⁶, Jari Koskenpato⁷, Veli-Jukka Anttila^{2

4}, Jyrki Tillonen¹, Reetta Satokari³, Perttu Arkkila^{2

8}

¹ Department of Gastroenterology, Päijät-Häme Central Hospital, Lahti, Finland.
² Faculty of Medicine, University of Helsinki, Helsinki, Finland.
³ Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
⁴ Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
⁵ Department of Gastroenterology, Helsinki University Hospital, Espoo, Finland.
⁶ Department of Gastroenterology, Porvoo Hospital, Porvoo, Finland.
⁷ Department of Gastroenterology, Aava Medical Centre, Helsinki, Finland.
⁸ Department of Gastroenterology, Helsinki University Hospital, Helsinki, Finland.

No abstract available

Publication types